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NEW LIGHT ON THE HISTORY OF PENICILLIN
by
RONALD HARE*
PENICILLIN WAS discovered by Alexander Fleming in September 1928 while he was a
member of the staff of the Inoculation Department (now the Wright Fleming
Institute) at St. Mary's Hospital, London, and had just been appointed Professor of
Bacteriology in the University of London. He had noticed an unusual phenomenon,
absence of fully developed colonies of a common microbe, Staphylococcus aureus,
round a large colony of a common mould, Penicillium notatum, on an old culture
plate. Research during the following winter showed that this had been due to the
production by the mould of a hitherto unknown substance which was unique in that,
although harmless to animals, it could kill disease-producing microbes. This naturally
suggested its employment for the treatment of the diseases caused by such microbes,
but proofofits value for this purpose was not obtained until twelve years later, when a
team ofworkers led by Professor Howard Florey in the Sir William Dunn School of
Pathology in the University ofOxford was successful. .2.3
Florey and his colleagues were wise enough to publish a definitive account of their
work soon afterwards.4 Unfortunately, Fleming did no such thing, contenting himself
with a few sentences or very short paragraphs in medical journals, most ofthem with
very limited circulation.' This, together with what Maurois had to say in his biography
of Fleming, whose English translation by Gerard Hopkins was published in 1959, has
provided most of what is known about the part played by its discoverer in the
development ofpenicillin as a therapeutic agent.6
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Although I had been working in the same department under Dr. John Freeman and
Dr. Leonard Colebrook from 1925 to 1930, and was well acquainted with chemo-
therapeutic thinking at the time and the techniques employed, I myselfplayed no part
in the discovery itself or the researches that followed, and I did not discuss them with
Fleming. Nor did I have anything to do with the composition of Maurois' biography.
However, soon after Fleming's death in 1955, I obtained as much information as
possible from Fleming's colleagues. I was unable to proceed further until 1968, when I
received photostats of sixteen pages from the laboratory notebook kept by Dr. Stuart
Craddock, who had been Fleming's assistant at the time of the discovery. These
enabled me to show, in a book published in 1970, that on scientific grounds alone there
were discrepancies in the series of events that led to the discovery, the source of the
mould, and what Fleming had said about the chemical researches. But I was unable to
put forward any very satisfactory reasons for Fleming's failure to demonstrate the
therapeutic value ofpenicillin.'
Much of this had been because I had been unable to locate or obtain access to
Fleming's laboratory notebooks. But in 1970, soon after the publication of my book,
they were deposited in the British Library. They have proved to be much less valuable
than had been anticipated. There are long breaks in the dating for which there is no
obvious reason, and the complete absence of some researches known to have been
carried out. To make matters worse, although the books are available for inspection,
they cannot be used or cited without the permission ofthe owner ofthe copyright, who
refused it for this article.*
Craddock's complete notebook for 1929 has also reached the British Library, and
shows that a number ofexperiments thought to have been carried out by Fleming had
actually been done by Craddock. He was also the chronicler of the chemical
researches, which were much more extensive than had been assumed. His invaluable
notebook has been available for use and quotation.8
With this new material it is possible to describe with a greater degree of accuracy
than has previously been possible the events that preceded and followed the discovery,
and to furnish more acceptable reasons for Fleming's failure to demonstrate its value
than he or his biographer had put forward. This is the main purpose ofthis paper.
THE DISCOVERY
In the paper reporting the discovery, Fleming described the phenomenon and the
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processes he thought had brought it about in the following terms:
While working with staphylococcus variants, a number ofculture-plates were set aside on the laboratory
bench and examined from time to time. In the examinations, these plates were necessarily exposed to the
air and they became contaminated with various micro-organisms. It was noticed that around a large
colony of a contaminating mould, the staphylococcus colonies became transparent and were obviously
undergoing lysis (see Fig. 1).9
There is no doubt that this explanation was based on the assumption that penicillin
acted on microbes in the same manner as lysozyme, which Fleming had discovered six
years previously after noticing a very similar phenomenon on an old culture plate.'0
For some years, this explanation went unchallenged, but in 1940, Professor A. D.
Gardner of Oxford found that pencillin acted on organisms in a very different fashion
from lysozyme in that it could only act on them during the very short phase in their
life history when they were actually dividing."
Since virtually all the organisms in fully developed colonies would be dead or dying,
doubts about Fleming's explanation for the phenomenon began to arise in Oxford,
which led to Dr. Margaret Jennings' attempts to produce dissolution of
staphylococcal colonies with high titre penicillin. These failed, the colonies remaining
intact (Fig. 2).12 Using even stronger solutions of penicillin, Dr. W. D. Foster was also
unable to produce any visible effect on fully developed colonies.'3
No alternative procedures that could have produced the phenomenon were
described until 1970, when I showed that it was possible to produce the phenomenon
in the conditions in which Fleming was operating by postponing growth of the
staphylococci until the spores of the mould had grown into a colony large enough to
produce penicillin. This could only be achieved if the plate had been contaminated
before or at the time it was being seeded with the staphylococci and its temperature
kept below 20°C for the next five days, following which a high temperature favoured
the development of the phenomenon. Study of the temperatures in London during
July, August, and September 1928 showed that there had been only nine days when
the weather had been continuously cold enough. Altogether these included two
Sundays and one Saturday, Fleming could have discovered penicillin if he seeded the
plate with staphylococci and contaminated it on Monday or Tuesday, 30 or 31 July.
It is impossible to confirm this theory because the pages recording the discovery and
those concerning the staphylococcal variants have disappeared from Fleming's
notebooks. In fact, nothing whatever is known about Fleming's activities from mid-
January 1928 until Craddock appeared on the scene at the end ofJuly.
At first sight, these minutiae may appear irrelevant, but if the phenomenon had
been produced in the manner Fleming thought it had, it would be a very common
occurrence in bacteriological laboratories all over the world, and Fleming could claim
credit only for observing something unusual and acting upon it. In doing so, he did
9 Fleming, op. cit., note I above, p. 226.
10 A. Fleming, 'On a remarkable bacteriolytic element found in tissues and secretions', Proc. R. Soc.
Lond., series B, 192 1-22, 98: 306-317.
"A. D. Gardner, 'Morphological effects of penicillin on bacteria', Nature, Lond.. 1940, 146: 837-838.
12 Florey et al., op cit., note 4 above, pp. 634, 1152.
"W. D. Foster, 'Sir Alexander Fleming as a bacteriologist', Makerere nied. J.. 1965, no. 8, 11-15.
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himself an injustice, because the stringent requirements in terms of time when the
mould reached the plate and the temperature to which it was subsequently subjected
render its accidental production almost impossible in countries with tropical or
continental climates, and very unusual in those with temperate climates. Fleming was
a great deal more fortunate than he ever realized.
The discovery probably occurred on Monday or Tuesday, 3 or 4 September 1928,
while Fleming, officially on holiday, was on a flying visit to London to assist a surgical
colleague with the treatment ofan abscess from which a haemolytic bacillus had been
isolated. It was probably while waiting for his colleague to appear that Fleming took
the opportunity to discover penicillin.
As to what occurred at the time, there are two separate accounts which, at first
sight, appear to be describing two separate events. They can, however, be reconciled.
The first to be published was that by D. Masters in his Miracle drug,'4 and quoted by
Ludovici in his unofficial biography ofFleming.'" It depends on what Dr. E. W. Todd
knew ofthe event. Todd shared Fleming's laboratory, but would have had his back to
Fleming's bench so that he could have heard but not seen what had been going on
there. This is described by Professor Merlin Pryce in a memorandum, a copy ofwhich
he was good enough to give me, and which is summarized in both Maurois' biography
and my own book. According to Pryce, Fleming had been looking at plates used for
researches on staphylococcal variant colonies and had already discarded many of
them. In the ordinary course ofevents, they would not have been looked at again. At
this point, Pryce arrived for a morning gossip, and Fleming started to show him plates
from the discard pile. One of them was the penicillin plate, the phenomenon was
noticed this time, a culture taken of the mould, and the plate can now be seen in the
British Museum.
Having discovered penicillin without looking for it and narrowly escaping failure to
do so, Fleming then returned to his country home to resume his interrupted holiday,
and did not start work again until the end ofSeptember.'6 Even so, it was not until the
end of October that an experiment with penicillin was recorded, and late November
before serious research can be said to have started.
THE SOURCE OF THE MOULD
The mould was sub-cultured at the time of its discovery and kept alive throughout
the following years. It was used by Florey and Chain in the early work in Oxford, and
even when large-scale production was required during 1944 and 1945. By that time, it
had been found that many strains ofPenicillia could produce some penicillin, and that
Fleming's was among the three best producers of penicillin, out of the hundreds that
many American workers had tested." It was, accordingly, a very exceptional strain of
this organism. This alone provoked interest in its source, but in view of the strict
requirements for the production of the phenomenon that lead to the discovery, its
14 D. Masters, Miracle drug, London, Eyre & Spottiswood, 1946, p. 26.
'L. J. Ludovici, Fleming, discoverer ofpenicillin. London, Andrew Dakers, 1952, p. 134.
hS. Craddock, 1968, personal communication.
17K. B. Roper, 'The development of improved penicillin-producing moulds', Ann. N. Y. Acad. Med..
1946-47,48:41
4II I I 4I o
- I 1 - _._v*s1'8
_ _ .,. o 4 t lllel I bt ;llal} \t lf *t'1 1{.'t-;1 1 --_[..........................................................!_|1____-_F...................................................................-*
ffis __ F _ .......................................... a t'4 > 4 tt} \- F_-...__. :_.'Xx.__E.._....:.__W
^_ _wE-:_ *_ i _ _ ^ w_ _ _ -_ _ _ _ _ '_k' f_ __ *_ f _ _ _ *_ * _ _ _ _Fr __ *_ - _ _
_ _ _s _ .P _ -_ _ _ ____._|__I _b...__*__I _...'3F.Y*__l _;ilL-_._*_11____I _r___.._*_lu_I _____*tN|_I ____wwI||_I _,_tiiv||__I _.-}|-_||_I _-LLa_^.........................................._-_-|_____I ___-_*|_| ___-_|I_t _1_-______._==
F.igure 1. Fleming's photograph of the original culture plate with his captions. (Fleming, op. cit.. footnote 1, facing
p. 228.)
1 N,)) it iII i II 111 c4 114 1) N'
"-,t aItII%,Io'cocci
4 0-t i Ir-,: I V.-.i--..U ;
. 3)
r' 0
o
_O N C,3cq
00
_~ >
C) W CZ E
- 0
CZ)
00
A)-
N
0-
C)Co
CZ C._
o
C)
. 0
-0
CO
0.
CZ
-o E
s 3
OC)
E .
0 C
0
.-C
E Z
CO
0
o
C)
0
~ C
0-'*
C) -
-0O L -_Figure 3. St. Mary's Hospital from Praed Street. The mycology laboratory was on the first floor of the
turret and Fleming's on the second. The remainder of the Inoculation Department was behind the
balconies on the farther side ofthe turret. (Photograph by the author.)IA
-
IA
U
C) C
0
.)
E
0
-5
C
e
0
0
0
C = a) o
.0
c)
-o
0E
00
3
a)
0
C)
UCT
C)-
-n 0
OD 2
UC)-
._
a)U
.C.:
it
p
000,Newlight on thehistoryofpenicillin
exceptional ability to produce penicillin may have played a part in this as well. Its
source is, therefore. a matter ofsome importance.
Nothing was said about the probable source ofthe mould until 1945, when Mr. G.
Lacken was preparing a film. He was told by Fleming that it had blown through the
window from Praed Street outside his laboratory.'8 Why he said this must remain a
mystery, for he had no proof and must have forgotten a good deal that disproves it.
Nevertheless, the story obtained wide publicity following its repetition by Maurois in
his biography, in which it was even suggested that, almost overnight, Fleming learned
enough mycology to isolate and identify ten other moulds.
In 1970, I pointed out'9 that the windows were seldom opened because they were too
difficult to reach, and because bacterial cultures always present on the window-sills
might fall on the heads of passers-by in the street below the opened windows. I also
showed that there had been, at the material time, another source of moulds in the
form of a mycological laboratory on the floor below and in the same turret as
Fleming's laboratory (Fig. 3). Since the mycologist in charge, Dr. C. J. La Touche,
had to contend with very primitive conditions, its atmosphere must have become
heavily contaminated by the spores of his moulds, so that they could have reached
Fleming's laboratory by way ofthe stairs and a door that was always open (Fig. 4).
Proof of this was aided by the fact that, soon after the discovery, La Touche gave
Fleming ten different moulds to enable him to ascertain how common a property the
production of antibiotics was amongst the moulds.20 These were tested, together with
three more obtained from elsewhere; only one produced an antibiotic. This was one of
La Touche's moulds. and this, according to Fleming in the original paper, had
'"exactly the same cultural characters" as the mould on the original plate, and,
although hedid not say so, ability to produce the same amount ofpenicillin.
There is, accordingly, good evidence that at the time of the discovery there was
present in the mycological laboratory downstairs an exactly similar mould, that it had
come upstairs to enter Fleming's laboratory by way ofthe door, and that Praed Street
and an open window played no part in thediscovery.
Why Fleming did not tell this story when asked, seventeen years later, whence the
mould had come, must remain a mystery. The most probable explanation is that at the
time he incriminated Praed Street and an open window as the source, the run-up to the
Nobel Prize elections was about to start in Sweden, for which reason it would have
been inadvisable to draw attention to the fact that the institute in which Fleming
worked could not keep its moulds in order.
PROPERTIES OF THE NEW SUBSTANCE
After preliminary experiments in early December, Fleming was joined by Dr.
Stuart Craddock on the twenty-first. Craddock had qualified in medicine in July, and
had been awarded a Research Scholarship to work under Fleming's direction. Despite
his lack ofexperience, he was responsible for many of the early experiments with the
new substance.
"I G. Lacken, Thestoryofpenicillin, London, Pilot Press, 1945.
19 Hare, op. cit., note 7 above, pp. 82-83.
20 C. J. La Touche, 1966, personal communication.
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It was soon found that penicillin could be produced by growing the mould at room
temperature in the laboratory's routine broth, which was made in small batches from
a tryptic digest of bullock's heart muscle. A pellicle formed on the surface, the fluid
below became bright yellow and was usually free of mould particles. Although they
could be removed by filtration without loss of penicillin, this was usually omitted.
Such a solution of pencillin was referred to in the laboratory as "mould juice" or,
more officially, as "the Inhibitor", until, some time in April when the paper was being
written, Fleming gave it its final name.
The penicillin produced could be detected by the now well-known ditch-plate
method, in which equal quantities of the culture and melted nutrient agar were
introduced into holes or gutters cut in the agar of a culture plate and allowed to set.
Cultures ofdifferent organisms were streaked over these areas from side to side ofthe
plate. It was then incubated overnight, and the inhibition ofgrowth along each streak
gave some indication ofthe amount ofpenicillin in the broth.
A more accurate method for estimating the pencillin content consisted in making
serial dilutions in fresh broth, to each of which were added a few drops of a
staphylococcal suspension. Following incubation, the highest dilution in which no
growth of the organisms had occurred was recorded as the titre. It was soon found
that after growth at room temperature for five to seven days the titre was generally
1/100 to 1/300 and very occasionally 1/600. Thereafter, it began to fall so that all but
a trace ofpencillin had gone after fourteen days.
It was also found that the new substance appeared to be harmless to man and
animals. Its effect on micro-organisms depended on the species, those found in or
producing diseases in the alimentary canal being insusceptible, whereas those from the
respiratory tract were killed. These properties naturally suggested the employment of
penicillin for two purposes: one was the treatment of infections; the second was its
incorporation in culture media to facilitate the growth of organisms whose isolation
had been difficult. This particularly applied to H. influenzae. Strange as it may seen,
Fleming spent a great deal more time on this aspect of penicillin than on its
therapeutic potentialities, and published several papers on it.2"
In regard to the treatment of infections by susceptible organisms such as
staphylococci, streptococci, and pneumococci, research along two separate lines was
required: first, an enquiry into the feasibility of producing a more concentrated and
purified solution than the broth cultures ofthe mould; and second, an attempted proof
in the laboratory of its probable therapeutic value. The remainder of this paper deals
with these two problems.
ATTEMPTS TO PRODUCE A CONCENTRATED AND PURIFIED SOLUTION OF PENICILLIN
For whatever purpose penicillin might be required, the broth cultures of the mould
were generally unsuitable, particularly if treatment of deep-seated infections was
2(a) Fleming, op. cit., note I above; (b) Fleming, op. cit., note 5(b) above; (c) Fleming, op. cit., note 5(c)
above; (d) A. Fleming, 'Selective bacteriostasis', Abstracts, Second International Congress of
Microbiology, 1936, p. 3; (e) A. Fleming and 1. H. Maclean, 'On the occurrence of influenza bacilli in the
mouths ofnormal people', Br. J. exper. Path.. 1930, 11: 127-134.
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contemplated. In the hope of overcoming this difficulty, Fleming suggested to Mr.
Frederick Ridley, who had been studying lysozyme under his supervision, that he
explore the possibility of producing a more satisfactory solution. Having had more
chemical training while an undergraduate than was usual at that time, Ridley agreed,
and started work during January 1929. He was allowed the assistance of Craddock,
who also kept the records, copies of which were placed on Fleming's bench every
morning. These seem to have disappeared, so that the only information available is
that found in Craddock's notebook.
These investigations were never published in the usual sense of the term, but in
1968, amongst photostats of sixteen pages of Craddock's notebook, the only
information then available, I found details of three experiments which, together with
the recollections of the two men, enabled me to describe the methods employed, the
many precautions that had to be taken, and the difficulties they had encountered.22
Now that Craddock's notebook is fully available, it is possible to describe four more
experiments.23
With regard to the method employed, suffice it to say that in most of their
experiments, quantities of about 100 ml of penicillin broth were evaporated under
vacuum at a temperature ofabout 40°C, the pH being adjusted before and at intervals
to 6.9 or below by the addition ofsulphuric or hydrochloric acid. Theevaporation was
stopped when only a few ml of a dark red fluid or a sticky mass was left. An organic
solvent was then added, the mixtures centrifuged, and the penicillin titre of the
supernatant determined.
In the first experiment dated 8 January, ether (volume not recorded) was added to
the mass after evaporation. A great deal of material did not go into solution, but the
ether itself became bright yellow and its titre was 1/1,000, considerably higher than
any ofthe many broth cultures ofthe mould they had tested.
In the second experiment, on 14 February, the culture had a titre of 1/300 and that
ofthe ether added to the mass after evaporation was much higher, 1/6,400.
Since these experiments clearly indicated that penicillin was soluble in ether,
advantage was taken ofthe fact that it does not mix with water to omit evaporation in
the next experiment on 20 February, and add it directly to the broth. It became bright
yellow and was separated from the culture fluid. There is no record of its titre, but its
spectrum of activity on different organisms was the same as that of penicillin. There
is, therefore, no doubt that they had found that penicillin, or something behaving in
the same manner, was soluble in ether.
Acetone had been employed as a solvent in another experiment, on 12 March, but,
although penicillin had gone into solution from a mass after evaporation, most of it
had evidently been lost in the process.
The next solvent to be employed was alcohol. Two experiments, on 20 March and
10 April, have already been described elsewhere, in which extracts with titres of 1/500
and 1/3,000 were obtained.24 Two more can be found in Craddock's notebook.25 In
22 Hare, op. cit., note 7 above, pp. 93-96.
21 Craddock, op. cit., note 8 above.
24 Hare, op. cit., note 7 above, pp. 95-96.
25 Craddock, op. cit., note 8 above.
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that of 16 March, 200 ml ofbroth culture with a titre of 1/250 was concentrated under
vacuum to 10 ml. This had a titre of 1/3,000. To it was added 90 ml of absolute
alcohol, and the mixture centrifuged. The titre of the supernatant was 1/400 and that
of the deposit below 1/10. The supernatant was then concentrated under vacuum to
10 ml, presumably to get rid of as much alcohol as possible. Its titre was 1/3,200.
Thus, practically all the penicillin had survived two separate evaporations and was in
solution in a mixture consisting largely ofwater.
In the experiment of 4 April, neither the quantity nor the titre of the culture was
recorded, but it was evaporated to dryness. To it was added 2 ml of absolute alcohol,
and the mixture allowed to stand for two hours. It was then centrifuged, the
supernatant removed, and 2 ml ofdistilled water added to the residue. The titre ofthe
supernatant was 1/8,000, and that ofthe residue, 1/4,000.
The results of all these experiments are summarized in Table 1. They show that
penicillin was not only soluble in three organic solvents but that, depending on the
quantity added, very high titres might be obtained, and, where the data permit
calculation, with very little loss in the process. A very considerable degree of
purification had also been obtained, judging by the amount of residue that had either
not gone into solution or been precipitated by the solvent. It must be added that there
are no indications in the records that the instability of penicillin had been a serious
problem or had caused any experiment to be discontinued.
Table 1. Solubility ofpenicillin
Date Solvent Culture fluid Extract
Volume Titre Volume Titre
Feb. 6 Ether N.S. N.S. N.S. 1/1,000
Feb. 14 Ether N.S. 1/300 N.S. 1/6,400
Mar. 12 Acetone N.S. 1/200 N.S. 1/200
Mar. 16 Alcohol 200 ml 1/250 lOml 1/3,200
Mar. 20 Alcohol 200 ml 1/100 50 ml 1/500
Apr. 4 Alcohol N.S. N.S. 2 ml 1/8,000
Apr. 10 Alcohol 1,200 ml 1/300 120 ml 1/3,000
N.S. = not stated.
(Source: Craddock, op. cit., footnote 8 above.)
For no very obvious reason, no attempts seem to have been made (or, at any rate,
recorded) to carry out what should have been the third step, transfer of the penicillin
from the solvent to a watery base suitable for intravenous injection.
Fleming reported these researches in the original paper under the heading of
Solubility in forty-six words, as follows:
8Newlight on the historyofpenicillin
Solubility. It is freely soluble in water and weak saline solutions. My colleague, Mr. Ridley, has found
that if penicillin is evaporated at a low temperature to a sticky mass the active principle can be
completely extracted by absolute alcohol. It is insoluble in ether or chloroform.26
It is all too obvious that Fleming can have known virtually nothing about these
researches and had not troubled to find out more about them, because both Ridley and
Craddock told me that they had not seen the paragraph before publication. It is
therefore not surprising that no mention is made of evaporation having been carried
out under a vacuum at a low temperature, that a low pH had been essential, and that
concentrations or extracts with very high titres had been obtained. Of much greater
importance are the mistakes, it being stated that penicillin was insoluble in ether, in
spite ofthe fact that two extracts had been obtained, one with a titre of 1/6,400, and a
third which contained something behaving in the same way as penicillin. Fleming also
stated that penicillin was insoluble in chloroform, which Ridley had not employed,
and acetone was ignored.
Why Fleming should have known so little about these investigations must be a
matter for speculation, but it must be mentioned that he had a limited knowledge of
chemistry. Therefore, he had failed to realize that the discovery that penicillin was
soluble in three solvents was of fundamental importance, and indicated that its
separation and concentration from the other constituents of the broth cultures would
not have been such a serious problem as that encountered with proteins, for example.
Fleming would have been much more impressed by the clumsy and temperamental
nature of the apparatus Ridley had been using and its unsuitability for the processing
of any quantity ofculture. This, together with the results obtained in other researches
to be described later, may have persuaded him that a preparation suitable for
intravenous injection was no longer a matter ofurgency and was too difficult to come
by.
Support for this conclusion comes from the fact that he never referred to these
investigations in any of his subsequent papers until the value of such a solution was
proved by Florey and his team at Oxford in 1941. Even so, all that Fleming had to say
about Ridley's work was that it had been a failure.2"
Although an alteration in Fleming's opinion ofpenicillin may have been responsible
for the sudden ending of these researches on 10 April, neither Ridley nor Craddock
suspected that this had been the reason. According to them, it was mostly because
they were getting tired of producing extracts by a method quite unsuitable for the
production of any quantity. But one thing is quite certain. There had been no quarrel
or other unpleasantness. On 13 May, Ridley went back to his previous researches with
experiments on the effect ofantiseptics on tears, which were followed by others on 30
May, 4, 14 and 15 June, 18 July, and still moreduring the autumn and winter.28 On 17
May, Craddock also branched off, to study the value of penicillin for the isolation of
the acne bacillus. This research occupied him for the rest of the year, but was not
26 Fleming, op. cit., note I above, p. 228.
27(a) A. Fleming, 'Penicillin; Robert Campbell oration', Ulster med. J., 1944, 13: 95-108. (b) Fleming,
op. cit., notes 5(d), 5(e), and 5(f) above.
28 F. Ridley, 1968, personal communication.
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published until long afterwards.29 Thus both men were available had they been
required.
A year or so later, unasked by Fleming but suggested by Professor W. W. C. Topley
at the London School of Hygiene, Raistrick and his colleagues, Clutterbuck and
Lovell, started to study penicillin and found that it was soluble in ether. But,
unfortunately, Raistrick seems to have been unaware that living things can produce
substances that disappear with great rapidity, such as complement and haemolysins,
but which by care and nursing can be kept active for quite long periods. When,
therefore, he found that penicillin might disappear in a few minutes when an ethereal
solution was allowed to evaporate on the bench, he lost his nerve and returned to his
study ofcompounds robust enough to be crystallized.30
Two years later, Dr. Lewis B. Holt, a professional chemist, became a member of
Wright's department at St. Mary's. Fleming suggested that he attempt the
concentration and purification ofpenicillin and referred him to the paper by Raistrick
et al., but said nothing whatever about Ridley's work. This was of small importance,
because Holt immediately appreciated the fact that ifthe new substance was soluble in
ether, other organic solvents might be employed as well. He chose amyl acetate and,
provided the pH was dropped to between 5 and 6, penicillin would go into solution.
But the losses were very heavy when attempts were made to transfer it to a solution of
sodium bicarbonate at a pH of8.0.31
Except for the abortive attempt by Reid in America,32 nothing further was done
until Chain attacked the problem in Oxford. With the assistance of six graduates, an
unspecified number of technicians, and a roomful of highly intricate apparatus, he
succeeded in producing enough penicillin to prove its value by treating experimentally-
infected animals.32b
LABORATORY ASSESSMENT OF THE THERAPEUTIC VALUE OF PENICILLIN
Before penicillin could justifiably be employed for the treatment ofhuman beings, a
laboratory investigation was an essential preliminary. But it is a striking fact that in
all Fleming's accounts of the development of penicillin, no detailed description of
what he had done in this connexion was included. What makes this even more
remarkable is his having spent a great deal of time and energy during the years
preceding the discovery in devising techniques for this very purpose.33
Before describing these techniques and the results he obtained, it is essential to
emphasize that, at the time penicillin was discovered, very little was known about
chemotherapy, and it was not until 1935, when the first of the sulphonamides was
introduced, that modern chemotherapy can be said to have been born. Before that,
29S. Craddock, 'Use ofpenicillin in cultivation of the acne bacillus', Lancet. 1942, i: 558-559.
10 P. W. Clutterbuck, R. Lovell, and H. Raistrick, 'The formation from glucose by members of the
Penicillium chrysogenum series of a pigment, an alkali soluble protein and penicillin - the antibacterial
substance of Fleming', Biochem.J., 1932, 26:1907.
"'L. Holt, 1965, personal communication.
"2(a) R. Reid, 'Some properties of a bacterial inhibitory substance produced by a mould',J. Bact., 1935,
29: 215. (b) Chain et al., op. cit., note 2 above.
"(a) A. Fleming, 'The action of chemical and physiological antiseptics in a septic wound', Br. J. Surg.,
1919-20, 7: 99-129. (b)A. Fleming, 'A comparison of the activities of antiseptics on bacteria and on
leucocytes', Proc. R. Soc. Lond., series B, 1924, 96:171-180.
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only two diseases could be cured by such methods. They were syphilis and relapsing
fever, by Ehrlich's Salvarsan and Neosalvarsan. Very little was then known about
their mode of action. It was generally assumed that they killed the spirochaetes
responsible in the same manner as did the strong but poisonous antiseptics, such as
phenol and mercury perchloride; but that the main difference was that their toxicity
was sufficiently low to enable them to be injected intravenously without serious
effects. Nevertheless, they retained sufficient toxicity to make it necessary to wait a
week before giving another dose.
It was naturally assumed that any new compound likely to be of value for the
treatment of the more acute and potentially fatal infections by streptococci,
staphylococci, and pneumococci would behave in the same manner, would have to be
administered intravenously, and would have to be sufficiently less toxic to allow
adequate doses to be given more frequently than had been possible with the arsenicals.
Against such a background it would be legitimate to suppose that the discovery ofa
compound with such basic properties as penicillin possessed would have been followed
by its intensive investigation at St. Mary's Hospital, with a view to its clinical
employment as soon as possible. But by that time, the Inoculation Department as a
whole had become extremely suspicious about the value of compounds with what
seemed similar characteristics. These compounds, advocated by commercial houses,
had proved to be frauds when tested clinically. Wright and Fleming had, accordingly,
taken it upon themselves to expose these frauds, the former in words,34 and the latter
with techniques." When, therefore, Fleming discovered penicillin, his first reaction
would have been to look for its defects rather than its merits. How to do this was still a
subject for debate, there being two schools ofthought.
One based its techniques on those originally employed by Ehrlich, who had assessed
his arsenicals by the effect they had on experimentally-infected animals such as mice,
rats, and rabbits. Similar procedures were still being used by his successors in German
laboratories, such as Hoerlein, Hegler, and Domagk in their search for new
therapeutic substances. It must be added that these methods enabled them to discover
the sulphonamides and to lay the foundations ofmodern chemotherapy.
The St. Mary's school, led by Wright, Fleming, and Colebrook, had grave doubts
about the value of the German methods. These doubts were never, so far as I know,
actually published but they were very much a part ofthe departmental doctrines. They
were based on three facts: first, the experimental infections were considered to be too
severe to serve as models of the normal human infections by such organisms; second,
the organisms were human pathogens so that any effect the "natural immunity"
mechanisms of the animal might have on the action of the substances under test might
fail to come into action; and third, the effect of locally applied substances to surface
infections could not be assessed for technical reasons given later in this paper.
Instead, the St. Mary's school employed in vitro methods, in which, to put it
crudely, human blood took the place ofanimals, the assumption being made that, as it
was the principal antibacterial mechanism in the body, any increase or decrease in its
34"A. E. Wright, 'A discourse on Ehrlich's "chemotherapy",' Lancet, 1927, ii: 1327-1334.
35Fleming, op. cit., notes 33(a) and 33(b) above.
11Ronald Hare
ability to kill organisms when potential therapeutic substances were added to it would
give some indications oftheir value in disease.
Although this method demonstrated the deficiencies ofthe many compounds on the
market which were clinical failures,36 no-one had yet shown whether it alone could
detect a compound likely to be successful. Nevertheless, in spite of this, Fleming had
implicit faith in the value of in vitro methods. Of several techniques he had invented,
one described in 1924 used home-made pieces ofapparatus ofwhich he was extremely
proud. They were called "slide cells" (Fig. 5) and were made in the following manner:
The slide cells in this method are made from two microscope slides separated by means of five strips of
vaselined paper arranged at intervals conversely to the long axis of the slides. By means ofthese strips of
paper, the space between the two slides is divided into four very thin compartments or cells open at each
end and which will contain rather more than 50 cmm ofblood.37
(a)
(b)
Figure 5. Slide cells (a) before and (b) after filling with mixtures of defibrinated blood, agent under
investigation, and microbes and sealed before incubation.
He used nothing more elaborate than thin capillary tubes, rubber teats, minute test-
tubes made in the laboratory from glass tubing, and microscope slides covered with
36 (a) Ibid. (b) R. M. Fry, 'The effect of sanocrysin on B. tuberculosis', Br. J. exper. Path., 1926-27, 7:
174-176. (c) L. Colebrook and R. Hare, 'On the bactericidal power of mecurochrome', ibid., 1927, 8:
109-114. (d) L. Colebrook, A study ofsome organic arsenical compounds with a view to their use in certain
streptococcal infections, (Medical Research Council Special Report Series, No. 11(), London, HMSO,
1928.
17 Fleming, op. cit., note 33(b) above, p. 171.
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wax on which to make the mixtures. All the cells contained 5c.mms. of human
defibrinated blood to which had been added 5c.mms. of suitable dilutions in saline of
overnight cultures of staphylococci or occasionally haemolytic streptococci, and
5c.mms. dilutions in saline ofthe substance under investigation. When all the cells had
been filled, the edges of the slides were sealed with a mixture of paraffin wax and
vaseline; they were then incubated for sixteen hours, at which time any surviving
organisms would havegrown into tiny colonies that could be counted with a hand lens.
In all these experiments a high proportion of the staphylococci or streptococci
usually employed failed to survive in the cell containing normal blood without any of
the compound under test. They had been ingested by the leucocytes and destroyed
inside the cells. When most of the compounds under investigation at that time, which
Fleming had tested by this method, were present in high enough concentration, they
would usually kill or at least prevent development of all the organisms. But when
smaller quantities of the compound were present, they might be in too low
concentration to prevent development of the organisms, but at the same time in
sufficient concentration to act on the leucocytes and diminish their ability to kill the
organisms. Because ofthis, the position at the infected focus might well be worse than
it had been without treatment. This is illustrated in Table 2, showing what occurred
when carbolic acid was employed.
Table2. Theeffect ofcarbolic acid on the bactericidal power ofhuman blood on slide cells
Final dilution ofcarbolic acid None 1/2,560 1/1,280 1/640 1/320
Number ofcolonies in each cell 2 7 31 100 0
(Source: Fleming, op. cit., footnote 33(b) above.)
Although this method of assessment could condemn a new, untried compound,
there was less certainty about its value for the detection and evaluation ofwhat might
become a successful compound, largely because no such compound had appeared and
been tested during the 1920s. The nearest approaches were the organic arsenicals
employed for the treatment of syphilis but which could also kill haemolytic
streptococci, for which reason they were being-seriously considered for the treatment
of infections by that organism. Fleming had also tested one of these compounds,
novarsenobillon, and found that it behaved in a manner quite different from most of
the compounds he had been testing. The results he obtained are given in Table 3, and
show that when present in clinically attainable concentration in blood, it could prevent
development ofany colonies, and there were no signsthat it harmed the leucocytes.
Table3. The effect ofnovarsenobillon on the bactericidal power ofhuman blood forhaemolytic
streptococci
Final dilution ofnovarsenobillon None 1/128,000 1/64,000 1/32,000 1/16,000
Number ofcolonies in each cell 58 32 11 0 0
(Source: Fleming, op. cit., footnote 39below.)
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Having perfected this technique in the early 1920s, Fleming tested almost every
substance ever suggested for the treatment of pyogenic infections. They included:
eusol, Dakin's solution, urea, alcohol, acetone, glycerine, hydrogen peroxide,
chloroform, chloramine T, carbolic acid, emetine, formalin, picric acid, iodine,
potassium permanganate, zinc permanganate, sodium salycilate, novarsenobillon,
quinine hydrochloride, flavine, brilliant green;38 to which must be added monsol,
samocrysin, and mercurochrome - all introduced after 1924.39 Then came a lull until
1935, when prontosil and then sulphanilamide appeared, which were duly tested by
Fleming soon afterwards;40 followed by sulphapyridine and sulphathiazole.4'
It is, therefore, not very surprising that early in December, with nothing better than
a crude broth culture of the mould, the only available source of penicillin, Fleming
tested its behaviour in slide cells. It is unfortunate that because of copyright
restrictions, the results cannot be reproduced here, but they were very much the same
as those in another experiment, carried out by Craddock on 19 February, the results
ofwhich are given in Table 4.
Table 4. The behaviour ofpenicillin in slide cells (19 February 1929)
Final dilution ofpenicillin broth None 1/12,000 1/1,200 1/120 1/12
Number ofstaphylococcal colonies in II 16 15 0 0
each cell
(Source: Craddock, op. cit., footnote 8 above.)
Up to this point penicillin had behaved in a manner that Fleming would have
considered indicative of a successful therapeutic substance that could be injected into
the bloodstream or employed for the treatment of surface infections by direct
application.
On 7 March, however, the outlook became less propitious as a result of an
experiment carried out by Fleming. This, too, cannot be reproduced because of
copyright, but Craddock carried out an almost identical experiment on 8 March,
which was performed in such a manner that the behaviour of penicillin in a simple
bacteriological medium was compared with its behaviour in defibrinated human
blood and serum from the same sample ofblood. The results are given in Table 5.
They are not so clear-cut as they were in Fleming's own experiment, but they
convey the same message, that penicillin was at its best in the bacteriological medium
but was only about half as active in blood and barely one-quarter as active in the
serum moiety ofblood.
Fleming would have concluded from these two experiments that there was
something in serum, and therefore in blood, that could in some undetermined manner
inactivate penicillin, and that other body fluids such as lymph and the exudate that
reaches an open wound, might similarly render penicillin less potent. It accordingly
"I Ibid.
19 A. Fleming, 'Discussion on the indications for and the value ofthe intravenous use ofgermicides', Proc.
R.Soc. Med., 1931,24: 808.
40 A. Fleming, 'Antiseptics and chemotherapy', ibid., 1940, 33: 127-136.
41 A. Fleming, 'In-vitro tests ofpenicillin potency', Lancet, 1942, i: 732-733.
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became imperative to ascertain whether this was likely to occur in the living animal.
Craddock therefore carried out the following experiment on 22 March:
A dose of 20cc ofpenicillin broth with a titre of 1/300 was injected intravenously into a rabbit weighing
2,100gm. Blood samples were taken before, immediately after, and at intervals during the next two
hours. Dilutions of the serum were made in broth, staphylococcal suspension was added and incubated
overnight.42
Table5. The behaviour ofpenicillin in slide cells (8 March 1929)
Dilutions ofpenicillin broth None 1/320 1/160 1/80 1/40 1/20
Number ofcolonies in each cell:
0 -05 per cent agar 86 76 61 35 0 0
Defibrinated blood 28 75 34 23 3 0
Serum 88 85 83 70 74
(Source: Craddock, op. cit., footnote 8 above.)
Table 6. Survival ofpenicillin in the circulating blood ofa rabbit after intravenous injection
(22 March 1929)
Dilutions ofthe serum Control 1/128 1/64 1/32 1/16 1/8 1/4 1/2
Before injection + + + + + + + +
Afterinjection + + + + _ _ _
30 mins after + + + + + + + +
60 mins after + + + + + + + +
120 mins after + + + + + + + +
+ = Growth - = No growth
(Source: Craddock, op. cit., footnote 8 above.)
The results are given in Table 6 and show that the penicillin content of the
circulating blood was much as might have been expected immediately after the
injection, but its rapid disappearance in less than thirty minutes was probably not. To
account for this, Fleming had three alternatives to choose from: (1) rapid excretion by
the kidneys; (2) a hastening of the decay in potency responsible for the instability of
penicillin when kept on the laboratory bench; (3) its inactivation as a result of its
combination with the tissues or the blood, similar to that now known as the protein
binding effect.43
Although, long afterwards, experience with human beings undergoing treatment by
intravenous injection would suggest that excretion by the kidneys had been the
42 Craddock, op. cit., note 8 above.
43 J. M. Bond, J. W. Lightbown, M. Barber and P. M. Waterworth, 'A comparison of four phenoxy-
penicillins', Br. med. J., 1963, ii: 956-961.
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principal reason for its rapid disappearance, Fleming seems to have favoured the third
alternative, its adsorption by the plasma, serum, or tissues, ifonly because something
of this nature had evidently occurred in slide cells. Craddock's comment in his
notebook, "This shows that the Inhibitor does not remain free in the serum for very
many minutes," is indicative ofthe opinion at the time.
Further confirmation that inactivation occurred by this method would have come
from Fleming's experiments with the chlorine-containing eusol and Carrell Dakin solu-
tions and the yellow dye, flavine. The latter, after intravenous injection, remained free
in the plasma for only eight minutes, by which time it had been adsorbed by the tissues
as indicated by their colour, while the plasma had lost the bright yellow colour it had
been immediately after the injection. Not surprisingly, these compounds had been
virtually useless when employed for the treatment of infected wounds during the first
world war."
On the other hand, Colebrook, Fleming's colleague, had found that the organic
arsenicals, Salvarsan and Neosalvarsan, could still be detected in the human
bloodstream six and sometimes more hours after an intravenous injection of a
therapeutic dose.45 And there was no doubt that such compounds could cure syphilis,
even when administered only once a week.
Although penicillin seemed to behave more like flavine than the arsenicals and
might be equally useless, there was a possibility that if it acted quickly enough, it
might deal with the organisms before its inactivation. In this connexion, Craddock
had already carried out the necessary experiment on 8 February, which he described
as follows:
To I cc volumes ofdilutions in broth ofpenicillin, were added 10c.mm. volumes ofa 1/1,000 dilution of
an overnight culture of staphylococci. The tubes were incubated at 37°C and at intervals, 10c.mm.
volumes were plated on nutrient agar and incubated for 24 hours when the number of colonies were
counted.46
Table 7. Time required to kill staphylococci (8 February 1929). Number ofstaphylococcal colonies on
solid medium
Time Penicillin dilutions in broth
None 1/80 1/40 1/20 1/10
Before incubation 27 27 27 27 27
2 hours after 116 73 51 48 23
4 1/2 after 00 13 1 2 5
8 1/2 after 00 0 0 0 0
12 1/2 after 00 0 0 0 0
00 = Uncountable
(Source: Craddock, op. cit., footnote 8 above.)
44 Fleming, op. cit., notes 33(a) and 39 above.
41 Colebrook, op. cit., note 36(d) above.
46 Craddock, op. cit., note 8 above.
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The results are given in Table 7. No attempt seems to have been made to ascertain
why the new substance allowed the organisms to multiply during the first two hours
and required more than another two and a half hours to kill all of them. But it must
have seemed obvious that if it survived in the bloodstream no longer than thirty
minutes following intravenous injection, it was unlikely to possess much value for the
treatment ofdeep-seated infections such as those of the meninges, lungs, peritoneum,
and bones, which, however penicillin was administered, would have required its
transportation to the infected area by the circulating blood. But, on the other hand, it
might be ofvalue in situations where it could be applied directly without close contact
with blood, such as infections of the skin, mucous membranes, ulcers, and open
wounds.
Nevertheless, ifthese were Fleming's conclusions, they were based on nothing more
substantial than four experiments in slide cells and one each in a rabbit and test-tubes.
But, although nothing further can be found, it is very difficult to believe that during
these two months nothing whatever had been done to ascertain the reasons for the
strange behaviour ofthe new substance.
But whatever Fleming did or did not do during these two months, it came to an end
on 10 May when the manuscript of the first paper was received by the Editor of the
British Journal ofExperimental Pathology. It provides invaluable information about
Fleming's opinion at that time.
In the first place, the slide cell experiments and that showing the rate of
disappearance of penicillin from the blood of the rabbit were not described or even
referred to. In the second place, all he had to say about the therapeutic value of
penicillin was contained in a small paragraph in the Discussion section, as follows:
Penicillin, in regard to infections with sensitive microbes, appears to have some advantage over the well-
known chemical antiseptics. A good sample will completely inhibit staphylococci, Streptococcus
pyogenes and pneumococcus in a dilution of I in 800. It is therefore a more powerful inhibitory agent
than is carbolic acid and it can be applied to an infected surface undiluted as it is non-irritant and non-
toxic. If applied, therefore, on a dressing, it will still be effective even when diluted 800 times, which is
more than can be said of the chemical antiseptics in use. Experiments in connection with its value in the
treatment ofpyogenic infections are in progress.4'
By far the most important thing about this paragraph is what is omitted, for
although the employment of penicillin for the treatment of surface infections is
mentioned, there is no reference to its employment for deep-seated infections or the
reasons for its omission. That this was deliberate and not an oversight is proved by the
fact that there are similar omissions in papers published two and three years later.48 In
still another paper, in which were described the performance in slide cells of all the
many compounds used at that time for deep-seated infections, penicillin was again not
mentioned, and no reasons were given for its omission.49 We must therefore conclude
that within eight months of the discovery, Fleming had sufficient doubts about the
value ofpenicillin for the treatment ofdeep-seated infections to make it inadvisable to
say anything about this aspect of its clinical employment. And it is a striking fact,
unnoticed by his biographer Maurois, that this opinion never left him. Even when he
47 Fleming, op. cit., note I above, pp. 235-236.
48 Fleming, op. cit., notes 5(b) and 5(c) above.
49 Fleming, op. cit., note 39 above.
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became a celebrity in 1942, he never claimed that he had wanted to treat the more
severe forms of infection for which penicillin was proving so valuable. Those who
knew him better than I did have confirmed this for me,50 and others have reached the
same conclusions from his writings.5
Fleming's doubts may also have been responsible for the sudden ending of the
chemical researches half way through April. Started at a time when the treatment of
deep-seated infections by intravenous therapy was not far off, the prospect of using
penicillin in this way had faded by that time, and with it the need for a suitable
solution or even an accurate description of the researches. But this does not excuse
Fleming's telling audiences in several countries many years later that Ridley's and
Craddock's work had been a failure.
Fleming's reservations may also account for his not testing penicillin in
experimentally infected animals. Quite apart from the departmental objections, this
would have required infecting the peritoneum first and then depending on the blood to
transport the agent from a subcutaneous, intramuscular, or intravenous injection
with, in Fleming's opinion, its inactivation on the way. The omission of these tests
would therefore have been deliberate. And it was not until 1935 when the
sulphonamides appeared, whose discovery and assessment both depended on animal
tests, that their value was finally realized. In spite of this, subsequent commentators
have not been slow to censure Fleming for their omission.52
On the other hand, Fleming had sufficient confidence in penicillin to suggest its
employment for the treatment of surface infections. But unfortunately, no-one had
invented an in vitro mimic of an infected wound or mucous membrane; only living
tissues would suffice. Here, small laboratory animals such as mice, rats, and rabbits
were virtually useless, it being impossible to obtain satisfactory infections and even
more difficult to treat them with saturated dressings or an irrigation apparatus.
Fleming accordingly chose the obvious alternative; treatment ofhuman beings. This .s
discussed in the next section.
Such would seem to have been the position reached eight months after the discovery,
when the first paper went in for publication. The paper itself certainly reflects
Fleming's opinion ofpenicillin as a therapeutic substance, for very little is said about
its properties and nothing whatever about what had become his standard method of
assessing the value of therapeutic substances; and what he had to say about the
chemical researches was inadequate and inaccurate.
But, on the other hand, a large part ofthe paper and even its title was occupied by
his study of the employment of penicillin to facilitate the isolation from mixed
cultures of influenza bacilli, which had occupied him for a great deal of the time
during the winter months and which were to be resumed in the autumn.
50 Personal communications: K. B. Rogers (1955); 1. H. Maclean (1958); S. Craddock (1968); F. Ridley
(1968).
51 Foster, op. cit., note 13 above. W. C. Noble, Coli, great healer oJ men. The biography ofDr. Leonard
Colebrook, FRS, London, Heinemann, 1974, p. 53.
52 R. Lovell, 1956, personal communication. E. Chain, 'Thirty years of penicillin therapy', Proc. R. Soc.
Lond. [Biol.l. 1971, 179: 293-319. G. Macfarlane, Howard Floreiy,Oxford University Press, 1979, p. 188.
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THE TREATMENT OF HUMAN INFECTIONS
Fleming's attempts to employ penicillin for the treatment oflocal surface infections
began soon after its discovery. The "patient" was Craddock, whose antrum (a nasal
sinus) had been troubling him for some time. It had become infected, and the aperture
by which it communicates with the nasal cavity had been enlarged by operation, so
that Fleming was able to inject penicillin broth into the antrum on 9 January 1929.
A sample of pus had been plated before treatment began, and had grown a mixed
flora of staphylococci and influenza bacilli. After instilling I cc of penicillin broth,
there was a copious effusion of fluid, and another culture three hours later grew one
colony of staphylococci and a few influenza bacilli. Although Craddock irrigated it
himself on several occasions during the next few days, the treatment was a failure,
probably because the pathogen involved had been what Fleming invariably called
Pfeiffer's bacillus (H. influenzae), which he found to be unaffected by penicillin.
This is the only "case" I have been able to find in the notebooks. But Craddock's
book contains a note dated 26 March recording the filtration ofpenicillin broth with a
titre of 1/600 "for the treatment of patients", but no further details are given.
Craddock was also involved some time later with Dr. Claude Dolman in the
preparation of several litres of penicillin broth for the oral treatment of a hospital
patient whose alimentary canal contained a large number ofenterococci thought to be
responsible for her rheumatoid arthritis but who, needless to say, did not benefit." But
eventually, in 1932, a cure was at last obtained when Dr. Keith Rogers, at that time a
medical student, contracted pneumococcal conjunctivitis in an eye required for a
shooting match. Fleming treated it with penicillin broth, and St. Mary's fielded its full
side.S4
Some time before this, a more systematic trial was attempted, but virtually nothing
is known about it. For such a purpose, Fleming had what would seem to have been
quite adequate resources. They consisted in nothing more than the provision ofbroth
cultures containing as much penicillin as possible, which should be ready whenever a
suitable patient appeared; either Fleming himself or a deputy was to be available at all
times to supervise the treatment. Close co-operation with the clinicians was also
essential.
With regard to the penicillin content of the cultures, one of the difficulties was the
wide variation in the titres. Although Fleming implied that 1/800 was relatively
common, this was a gross exaggeration, 1/100 to 1/300 being more usual.
No attempts seem to have been made to carry out a systematic enquiry to ascertain
how the yield might be improved and standardized, and, according to Craddock, they
seem to have been content to use the routine broth ofthe laboratory, no two batches of
which can have been the same, for they consisted ofonly a few litres of a tryptic digest
of bullock's heart muscle. Whether or not the Czapek Dox medium was considered is
not known, but at that time synthetic media were shunned by Fleming and his
colleagues; they were not rich enough. Because of this, the titre of the broth they
employed must have been governed by luck more than anything else.
51 C. Dolman, 1955, personal communication.
54 K. B. Rogers, 1955, personal communication.
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Another problem was the instability of the new substance. Fleming quoted an
experiment in the first paper, showing that practically all activity had disappeared
after fourteen days at room temperature. But it was soon found that the pH played an
important part. Usually as high as 8.5 when the titre was at its peak, it had been found
by Craddock that if it was brought down to 6.8 or lower and stored at 0°C, its useful
life might be prolonged considerably. In a later paper, it was said to be as much as
three months." Somewhat similar findings were reported by Raistrick and his
colleagues.56
An additional measure designed to provide active penicillin was adopted; it was
made a duty of every new recruit of Fleming's department to set up cultures of the
mould on a certain day every week (probably Monday or Tuesday) so that potent
penicillin would be available during the next week."
Thus, although Fleming frequently complained that the instability ofpenicillin had
hindered him, it is difficult to believe that with suitable organization this could not
have been largely prevented. And certainly, the instability of penicillin does not
appear to have been a problem when it was employed for selective media, as it
continued to be for several years after thediscovery.
Material needs in the form of glassware, and equipment for sterilization and
filtration were no problem. Nor did he require much assistance, and, in any event, he
nearly always had a Research Scholar working for him. Craddock, for example,
remained with him until the end of 1929, when his place was taken by Dr. Claude
Dolman, who did not leave until August 1931.58
Obtaining patients to treat seems to have been Fleming's biggest problem. It is
probable that the ophthalmologists were approached first ofall, because conjunctivitis
was an almost perfect infection for his purpose, and, since Ridley divided his time
between their department and Fleming's for several years following the discovery, he
would have been a useful link, but they certainly played no part.
Fleming seems to have obtained more co-operation from the general surgeons, but
all that can be gleaned about these investigations comes from scraps ofinformation in
papers at intervals over a period ofthirteen years. The first three59 show that there had
evidently been a delay of one to two years before the trial had started, that what were
called "indolent septic wounds" had been treated, that the results obtained had been
"superior to dressings containing potent chemicals", and that these were all over by
1931, largely, it would seem, "because of the amount of trouble necessary for its
[penicillin's] preparation and the difficulty in maintaining its potency for more than a
few weeks". But nowhere was it stated what was meant by "indolent septic wounds",
how long the treatment lasted, the organisms involved, and even the number of
patients treated.
Following these attempts, Fleming did not refer to the therapeutic value of
penicillin in any of his publications during the next nine years, but was heavily
" Fleming, op. cit., note 5(c) above.
16 Clutterbuck et al., op. cit., note 30 above.
57 Personal communications: K. B. Rogers(1955); C. Dolman (1955).
'8 Personal communications: S. Craddock (1968); C. Dolman (1955).
"9 Fleming, op. cit., notes 1, 39, and 5(c) above.
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involved in other matters such as selective media,60 staphylococcal toxoid and anti-
toxin (following their discovery),6' and, when they appeared, the sulphonamides.62
LATER DEVELOPMENTS
On 24 August 1940, the first ofthe Oxford papers was published, demonstrating the
value of penicillin for the treatment of experimentally infected animals,63 and on 2
September, Fleming went to Oxford where he was given a small sample of one of
Chain's partially purified preparations. This was tested in slide cells and found to be
capable ofproducing complete inhibition ofstaphylococci in human blood in dilutions
as high as 1/320,000 (Table 8).64 This may well have vindicated slide cells in Fleming's
opinion as a method ofassessment. And in any event, any inactivation that may have
occurred could be discounted with so powerful a solution.
Table 8. The behaviour ofone ofChain's early preparations in slide cells
Final dilutions ofpenicillin None 1/640,000 1/320,000 1/ 160,000 1/80,000 1/40,000
Number ofstaphylococcal 28 23 0 0 0 0
colonies in each cell
(Source: Fleming, op. cit., footnote 41 above.)
The results obtained by Florey and his colleagues must have made Fleming realize
that he would soon have to find excuses for the long delay in the introduction of
penicillin into medical practice, for which he was largely responsible. Nevertheless, he
was not very forthcoming in what he had to say. The first sign of this occurred in a
paper read to an audience ofdentists at the Royal Society of Medicine in April 1941,
which contained the following:
About 1930 it was used as a dressing on a few septic wounds with favourable results but as in peace time,
septic wounds are uncommon in hospitals and as the potency of penicillin rapidly disappeared on
keeping, the therapeutic aspect ofpenicillin was dropped.'3
Only five months later came the second of the Oxford papers, firmly establishing
penicillin as a curative agent for human infections and soon afterwards, an annotation
in the British Medical Journal which stated that "Penicillin does not appear to have
been considered as possibly useful from any other point of view than for the isolation
oforganisms". This galvanized Fleming into publishing a letter in the samejournal on
13 September, in which he said,
Prior to the second article cited (1931)66 a few tentative observations had been made on the effect oflocal
application ofthe unconcentrated culture to septic wounds(chiefly carbuncles and sinuses). Although the
60 Fleming, op. cit., note 21(d) above.
61 Fleming and Maclean, op. cit., note 21 (e) above. A. Fleming, 'Recent advances in vaccine therapy', Br.
med. J.. 1939, ii: 99-104.
62A. Fleming, 'Serum and vaccine therapy in combination with sulphanilamide or M and B 693',
Proc. R. Soc. Med., 1939, 32: 911-920.
61 Chain etal.. op. cit., note 2 above.
64 (a) A. Fleming, L. Colebrook, E. E. Lewis, and R. Mowlem, 'Chemotherapy and wound infection',
Proc. R. Soc. Med., 1941, 34: 337-350, p. 342. (b) Fleming, op. cit., note 41 above.
65 Fleming et al., op. cit., note 64 (a) above, p. 342.
66 Fleming, op. cit., note 5 (b) above.
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results were considered favourable, there was no miraculous success.67
Although these two quotations seem very much the same, there are important
differences. The first suggests to anyone knowing Fleming's previous history that he
had wanted to treat the civilian equivalent of the many acutely infected gunshot
wounds he had seen in France during the First World War. And nine months after his
lecture, Dr. Ethel Florey and Dr. R. E. 0. Williams started their study of these
civilian equivalents at the Birmingham Accident Hospital in the first controlled trial
ofthe new substance.68
But Fleming's letter of 13 September shows, what he had never revealed up to that
time, that the infections he had actually treated had been "carbuncles and sinuses"
and very different from the "septic wounds" he had wanted to treat. Nor were they
suitable, because they would have become chronic and anatomically unfitted for the
application ofan irrigation apparatus or saturated dressings.
Fleming never gave the reasons why he had treated such unsatisfactory infections
until he became a celebrity a year later and could be more candid about the behaviour
of the surgeons. Much the same story was told in places as far apart as Belfast,
London, America, and Stockholm.69 The following extract from a speech to an
audience of surgeons at the Mayo Clinic is typical ofall ofthem:
However, penicillin is a very unstable substance, as you know. The culture of Penicillium notatum might
be good today and in a few days time would have lost its power completely. We tried a little in clinical
work, but not much. When we went to the wards and asked the surgeons if they had any septic cases we
could try it on they always said, like most surgeons in most places, I think, that they had none. Then
perhaps they come along sometime afterwards and say,'Have you any of that stuff, I have a case I might
try it on?'. As likely as not, by that time the potency of the penicillin had faded away. We tried to
concentrate the penicillin but we were bacteriologists, not chemists, and we failed.70
Of the three excuses put forward, little credence may be given to the lack of a
concentrated solution of penicillin, if only because he had never suggested it in any of
his papers until the value of such a preparation was demonstrated by the Oxford
workers in 1941. Nor is it possible to accept instability ofpenicillin, in view ofthe fact
that a technique for its preservation for as long as three months had been introduced
before 1932. This leaves the third excuse, difficulties with the clinicians. This may have
been the real reason for the failure of the trials, because they had reacted in a manner
that could have been predicted. Following their promise of co-operation, they had
evidently had second thoughts about allowing him access to the acute and potentially
dangerous infections he had wanted to treat, when they realized that the new remedy
consisted of nothing more than broth in which a mould had grown and which was the
fifth in a series of remedies, all based on what seemed, at the time, impeccable
scientific evidence which Wright's department had been advocating during the
preceding twenty years. These had included vaccine therapy before the First World
War, hypertonic saline during the war, and immuno-transfusion after it, and the
arsenicals for streptococcal infections, all of which had proved dismal failures in
practice.
A. Fleming, [correspondence] 'Penicillin', Br. med. J.. 1941, ii: 386.
6 M. E. Florey and R. E.G. Williams, 'Hand infections treated with penicillin', Lancet, 1944,i: 73-81.
69 Fleming, op. cit., notes 27(a), 5(d), 5(e), and 5(f) above.
70 Fleming, op. cit., note 5 (e) above, p. 65.
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When, therefore, an acute infection appeared in their wards, Fleming was
"forgotten" and he never heard about it. But carbuncles and sinuses were another
matter. The acute phase was long past and spread of the infection unlikely to occur.
Besides, the patients were occupying beds wanted for much more interesting cases. If
Fleming had something that could cure such infections, it was worth trying. With co-
operation like this, it is not surprising that he gave up the struggle.
Nevertheless, the surgeons were not entirely to blame, for persuasion ofunwilling or
sceptical colleagues was not one of Fleming's talents, and he does not seem to have
realized that co-operation with clinicians who spent only a few hours a week in their
hospitals required more than promises. Dr. Reba Willitts and I had experience ofthis
during a bacteriological investigation in a general hospital that required access to
wound infections similar to those wanted by Fleming. Here, the clinicians were willing
to co-operate, but we soon found that unless one of us went to their wards every day
and cross-examined the sisters, we might never have heard about the infections which
were, incidentally, much more common than the surgeons had led us to believe." A
few minutes of Fleming's time every day might have given him all he wanted. In the
circumstances, it is not very surprising that the trials petered out with nothing very
definite to report. Fleming busied himself with other activities, and until his death in
1955, his excuses remained very much the same.
When, however, Maurois' biography was being written, it was impossible to conceal
the fact that Fleming had failed to exhibit the fire and energy in his dealings with the
surgeons required of someone with a passionate faith in his discovery. Maurois
accordingly countered with an entirely new excuse based on doubts about the value or
future of antibacterial chemotherapy so frequently expressed by Fleming's chief,
Almroth Wright. Certainly, according to Dr. V. D. Allison, Fleming's one-time
colleague, Wright had been the reverse of enthusiastic about the curative value of
penicillin when the manuscript of the first paper was submitted for publication. So
much so, that he had demanded the omission of the short paragraph suggesting its
employment for surface infections."2 Fleming stood his ground, and the paragraph
was published without alteration.
That Wright would behave in this manner could have been predicted, because he
would have asked how penicillin behaved in slide cells and why all the information on
the subject had been omitted, if only because he had played a part in their invention
and used them as often as did Fleming. On being told, he would have made the
obvious comment that there was insufficient evidence to justify any statement about
the therapeutic value ofthe new substance.
Assuming that Wright's behaviour would have made it difficult for Fleming to ask
for special help or facilities, Maurois succeeded so successfully in laying the blame on
Wright for Fleming's failure to prove the value of penicillin that this episode has
become an important part ofthe penicillin myth.
71 R. Hare and R. E. Willitts, 'The source and prevention of septic infection of wounds', Canad.
Med. Assoc. J., 1941, 44: 230-237. R. Hare and R. E. Willitts, 'The bacteriology of recently
inflicted wounds with special reference to haemolytic streptococci and staphylococci', ibid., 1942, 46:
23-30.
72 V. D. Allison, [correspondence] 'Fifty years ofpenicillin', Br. med. J., 1979, i: 1625.
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Such were what might be called the official excuses for the long delay in the
development ofpenicillin that followed its discovery, which were put forward at a time
when its therapeutic value had been firmly established and Fleming had become a
celebrity. But it is very doubtful whether they were the real reasons for his inactivity
that lasted from 1930 until 1940, when others completed the story for him. For, as
described in this communication, soon after the discovery what seemed to be good
scientific evidence had been found that penicillin was unlikely to be ofmuch value as a
therapeutic substance. This may well have generated doubts in his mind about the
feasibility ofspending a great deal oftime and energy on further research with nothing
of any value at the end of it. Rather than take this risk, he allowed penicillin to lie
fallow while hepursued what seemed more profitable lines ofresearch.
Why the researches that prompted him to do this were never published or referred
to, even when he had become a celebrity and a Nobel Laureate, will never be known.
But they would have been much better than his laying the blame on the clinicians, the
chemists, and even his own assistants for his own failure to follow up his discovery.
SUMMARY
The main objective of this communication is a review of the reasons for Fleming's
failure to prove the therapeutic value ofpenicillin, in the light of information that has
become available during the past decade.
The principal reason would seem to have been the behaviour of penicillin in
laboratory tests which Fleming had devised five years before the discovery. He had
implicit faith in these tests, which he was to employ at intervals during the twelve
years that followed the discovery for the assessment of the therapeutic value of any
compound put forward as an agent for the treatment of infections by pyogenic
organisms. First employed only two months after its discovery, penicillin behaved in a
manner indicative of a compound that was likely to be of therapeutic value for the
treatment of such infections. But another series of tests three months later suggested
that penicillin could become rapidly inactivated by blood, particularly its fluid
elements (and possibly those of the tissues as well), to such an extent that it seemed
unlikely that penicillin could be of much value for the treatment of any form of
infection that necessitated its transportation by the bloodstream (such as meningitis,
pneumonia, and peritonitis).
There was, however, a possibility that penicillin might be ofvalue for the treatment
of surface infections, such as those of the conjunctiva and mucous membranes, and
open wounds, where it could be applied directly with less risk ofinactivation.
These limitations in the value of penicillin and the investigations that had led to
them were never published or even referred to in any of Fleming's communications.
But it is a striking fact that he never advocated the employment of penicillin for deep-
seated infections. He not only suggested its employment for surface infections, but
attempted to treat them. These failed for a variety of reasons, including the lack of a
sufficiently stable and concentrated solution ofpenicillin, and inadequate co-operation
on the part ofthe clinicians.
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